Brief: RTW Biotech Opp. Says Avere To Go Public Via Reverse Merger With NextCure
12/08/2026 07:27
BRIEF-RTW Biotech Opp. Says Avere To Go Public Via Reverse Merger With NextCure Aug 12 (Reuters) - RTW Biotech Opportunities Ltd RTW.L:
RTW BIOTECH OPP. - AVERE THERAPEUTICS TO MERGE WITH NEXTCURE INC.
RTW BIOTECH OPPORTUNITIES - AVERE TO GO PUBLIC VIA REVERSE MERGER WITH NEXTCURE
RTW BIOTECH OPPORTUNITIES - AVERE RAISES $820 MILLION ACROSS TWO PRIVATE PLACEMENTS
RTW BIOTECH OPPORTUNITIES - AVERE ANNOUNCES $500 MILLION PRIVATE PLACEMENT FOLLOWING $320 MILLION PRIVATE PLACEMENT
RTW BIOTECH OPPORTUNITIES - COMBINED COMPANY TO TRADE ON NASDAQ AS AVERE THERAPEUTICS UNDER TICKER AVRX
RTW BIOTECH OPPORTUNITIES - PROCEEDS TO FUND AVR-001 THROUGH PHASE 2B AND PHASE 3 TRIALS IN PSORIASIS AND ULCERATIVE COLITIS
Source text: ID:nRSL2609Qa
Further company coverage: RTW.L
((Reuters.Briefs@thomsonreuters.com;;))